Literature DB >> 20705758

Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.

Shintaro Nakao1, Souska Zandi, Yasuaki Hata, Shuhei Kawahara, Ryoichi Arita, Alexander Schering, Dawei Sun, Mark I Melhorn, Yasuhiro Ito, Nuria Lara-Castillo, Tatsuro Ishibashi, Ali Hafezi-Moghadam.   

Abstract

Angio- and lymphangiogenesis are inherently related processes. However, how blood and lymphatic vessels regulate each other is unknown. This work introduces a novel mechanism explaining the temporal and spatial relation of blood and lymphatic vessels. Vascular endothelial growth factor-A (VEGF-A) surprisingly reduced VEGF-C in the supernatant of blood vessel endothelial cells, suggesting growth factor (GF) clearance by the growing endothelium. The orientation of lymphatic sprouting toward angiogenic vessels and away from exogenous GFs was VEGF-C dependent. In vivo molecular imaging revealed higher VEGF receptor (R)-2 in angiogenic tips compared with normal vessels. Consistently, lymphatic growth was impeded in the angiogenic front. VEGF-C/R-2 complex in the cytoplasm of VEGF-A-treated endothelium indicated that receptor-mediated internalization causes GF clearance from the extracellular matrix. GF clearance by receptor-mediated internalization is a new paradigm explaining various characteristics of lymphatics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705758      PMCID: PMC3035069          DOI: 10.1182/blood-2010-02-267427

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Lymphangiogenesis and cancer: meeting report.

Authors:  Kari Alitalo; Suresh Mohla; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

Review 2.  Molecular biology and pathology of lymphangiogenesis.

Authors:  Terhi Karpanen; Kari Alitalo
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

3.  VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.

Authors:  R Valtola; P Salven; P Heikkilä; J Taipale; H Joensuu; M Rehn; T Pihlajaniemi; H Weich; R deWaal; K Alitalo
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.

Authors:  Kosuke Watari; Shintaro Nakao; Abbas Fotovati; Yuji Basaki; Fumihito Hosoi; Biborka Bereczky; Ryuichi Higuchi; Tomofumi Miyamoto; Michihiko Kuwano; Mayumi Ono
Journal:  Biochem Biophys Res Commun       Date:  2008-10-23       Impact factor: 3.575

5.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Authors:  Romulo J C Albuquerque; Takahiko Hayashi; Won Gil Cho; Mark E Kleinman; Sami Dridi; Atsunobu Takeda; Judit Z Baffi; Kiyoshi Yamada; Hiroki Kaneko; Martha G Green; Joe Chappell; Jörg Wilting; Herbert A Weich; Satoru Yamagami; Shiro Amano; Nobuhisa Mizuki; Jonathan S Alexander; Martha L Peterson; Rolf A Brekken; Masanori Hirashima; Seema Capoor; Tomohiko Usui; Balamurali K Ambati; Jayakrishna Ambati
Journal:  Nat Med       Date:  2009-08-09       Impact factor: 53.440

6.  In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis.

Authors:  Shinsuke Miyahara; Lama Almulki; Kousuke Noda; Toru Nakazawa; Toshio Hisatomi; Shintaro Nakao; Kennard L Thomas; Alexander Schering; Souska Zandi; Sonja Frimmel; Faryan Tayyari; Rebecca C Garland; Joan W Miller; Evangelos S Gragoudas; Sharmila Masli; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2008-01-23       Impact factor: 5.191

7.  Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.

Authors:  Shintaro Nakao; Yasuaki Hata; Muneki Miura; Kousuke Noda; Yusuke N Kimura; Shuhei Kawahara; Takeshi Kita; Toshio Hisatomi; Toru Nakazawa; Yiping Jin; M Reza Dana; Michihiko Kuwano; Mayumi Ono; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

Review 8.  Vascular endothelial growth factor.

Authors:  Napoleone Ferrara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-22       Impact factor: 8.311

9.  VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.

Authors:  Satoshi Hirakawa; Shohta Kodama; Rainer Kunstfeld; Kentaro Kajiya; Lawrence F Brown; Michael Detmar
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.

Authors:  Steven Swendeman; Karen Mendelson; Gisela Weskamp; Keisuke Horiuchi; Urban Deutsch; Peggy Scherle; Andrea Hooper; Shahin Rafii; Carl P Blobel
Journal:  Circ Res       Date:  2008-09-25       Impact factor: 17.367

View more
  24 in total

1.  Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.

Authors:  Max M Gong; Karina M Lugo-Cintron; Bridget R White; Sheena C Kerr; Paul M Harari; David J Beebe
Journal:  Biomaterials       Date:  2019-05-25       Impact factor: 12.479

2.  Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration.

Authors:  Shintaro Nakao; Souska Zandi; Nuria Lara-Castillo; Mahdi Taher; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

Review 3.  Molecular underpinnings of corneal angiogenesis: advances over the past decade.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  Molecular imaging reveals elevated VEGFR-2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis.

Authors:  Dawei Sun; Shintaro Nakao; Fang Xie; Souska Zandi; Abouzar Bagheri; Mozhgan Rezaei Kanavi; Shahram Samiei; Zahra-Soheila Soheili; Sonja Frimmel; Zhongyu Zhang; Zsolt Ablonczy; Hamid Ahmadieh; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2014-06-05       Impact factor: 5.191

Review 5.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

6.  Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.

Authors:  Sungwoon Lee; Seung-Sik Rho; Hyojin Park; Jeong Ae Park; Jihye Kim; In-Kyu Lee; Gou Young Koh; Naoki Mochizuki; Young-Myeong Kim; Young-Guen Kwon
Journal:  J Clin Invest       Date:  2016-12-19       Impact factor: 14.808

7.  Lack of lymphatics and lymph node-mediated immunity in choroidal neovascularization.

Authors:  Shintaro Nakao; Souska Zandi; Ri-ichiro Kohno; Dawei Sun; Takahito Nakama; Keijiro Ishikawa; Shigeo Yoshida; Hiroshi Enaida; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-03       Impact factor: 4.799

8.  Cathepsin B-mediated CD18 shedding regulates leukocyte recruitment from angiogenic vessels.

Authors:  Shintaro Nakao; Souska Zandi; Dawei Sun; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

9.  Relationships between lymphangiogenesis and angiogenesis during inflammation in rat mesentery microvascular networks.

Authors:  Richard S Sweat; Peter C Stapor; Walter L Murfee
Journal:  Lymphat Res Biol       Date:  2012-12       Impact factor: 2.589

10.  Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.

Authors:  Parisa Emami-Naeini; Thomas H Dohlman; Masahiro Omoto; Takaaki Hattori; Yihe Chen; Hyun Soo Lee; Sunil K Chauhan; Reza Dana
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-05       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.